Alcohol Consumption, Genetic Risk, and Intraocular Pressure and Glaucoma: The Canadian Longitudinal Study on Aging.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
03 07 2023
Historique:
medline: 7 7 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

The purpose of this study was to examine the association of alcohol consumption with intraocular pressure (IOP) and glaucoma and to assess whether any associations are modified by a glaucoma polygenic risk score (PRS). Cross-sectional analysis of data from the Canadian Longitudinal Study on Aging Comprehensive Cohort, consisting of 30,097 adults ages 45 to 85 years, was done. Data were collected from 2012 to 2015. Alcohol consumption frequency (never, occasional, weekly, and daily) and type (red wine, white wine, beer, liquor, and other) were measured by an interviewer-administered questionnaire. Total alcohol intake (grams/week) was estimated. IOP was measured in mm Hg using the Reichert Ocular Response Analyzer. Participants reported a diagnosis of glaucoma from a doctor. Logistic and linear regression models were used to adjust for demographic, behavioral, and health variables. Daily drinkers had higher IOP compared to those who never drank (β = 0.45, 95% confidence interval (CI) = 0.05, 0.86). An increase in total weekly alcohol intake (per 5 drinks) was also associated with higher IOP (β = 0.20, 95% CI = 0.15, 0.26). The association between total alcohol intake and IOP was stronger in those with a higher genetic risk of glaucoma (P for interaction term = 0.041). There were 1525 people who reported being diagnosed with glaucoma. Alcohol consumption frequency and total alcohol intake were not associated with glaucoma. Alcohol frequency and total alcohol intake were associated with elevated IOP but not with glaucoma. The PRS modified the association between total alcohol intake and IOP. Findings should be confirmed in longitudinal analyses.

Identifiants

pubmed: 37405759
pii: 2791274
doi: 10.1167/iovs.64.10.3
pmc: PMC10327959
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Subventions

Organisme : CIHR
ID : LSA 94473
Pays : Canada
Organisme : CIHR
ID : PJT-180615
Pays : Canada

Références

Int J Epidemiol. 2019 Dec 1;48(6):1752-1753j
pubmed: 31633757
Alcohol. 2023 Mar;107:19-27
pubmed: 35940508
Transl Vis Sci Technol. 2019 Apr 04;8(2):10
pubmed: 30972231
Ophthalmology. 2005 Jul;112(7):1186-91
pubmed: 15939473
Cell. 2019 Mar 21;177(1):26-31
pubmed: 30901543
Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109130
pubmed: 34773776
Nutrients. 2020 Oct 26;12(11):
pubmed: 33114701
Invest Ophthalmol Vis Sci. 2009 May;50(5):2040-3
pubmed: 19151388
Ophthalmology. 2020 Jul;127(7):901-907
pubmed: 32081492
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Arch Ophthalmol. 2011 Jun;129(6):767-72
pubmed: 21320952
Arch Ophthalmol. 2005 Mar;123(3):381-6
pubmed: 15767482
Nutrients. 2020 Aug 12;12(8):
pubmed: 32806703
J Cell Physiol. 2015 Mar;230(3):510-25
pubmed: 25216121
Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1841-50
pubmed: 26340868
Nat Genet. 2020 Feb;52(2):160-166
pubmed: 31959993
Alcohol Health Res World. 1997;21(1):84-92
pubmed: 15706766
Nutrients. 2015 Aug 04;7(8):6362-74
pubmed: 26247965
Invest Ophthalmol Vis Sci. 2004 Jan;45(1):59-62
pubmed: 14691154
Rejuvenation Res. 2007 Sep;10(3):377-86
pubmed: 17708689
PLoS Genet. 2012;8(5):e1002611
pubmed: 22570627
Arch Ophthalmol. 1997 Dec;115(12):1572-6
pubmed: 9400792
J Clin Endocrinol Metab. 2008 Mar;93(3):750-7
pubmed: 18073316
Nutrients. 2021 Sep 11;13(9):
pubmed: 34579050
Ophthalmic Physiol Opt. 1986;6(1):95-9
pubmed: 3714283
Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):871-80
pubmed: 23364356
PLoS One. 2013;8(1):e55573
pubmed: 23383229
Ophthalmology. 2021 Jun;128(6):866-876
pubmed: 33333105
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Hypertension. 2005 May;45(5):874-9
pubmed: 15837829
BMJ Open. 2022 Mar 10;12(3):e059021
pubmed: 35273064
Br J Ophthalmol. 2008 Aug;92(8):1125-8
pubmed: 18653607
Ophthalmology. 2022 Jun;129(6):637-652
pubmed: 35101531
Nutrients. 2018 Oct 17;10(10):
pubmed: 30336568
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Ophthalmology. 2005 Jul;112(7):1177-85
pubmed: 15921747
Ophthalmol Glaucoma. 2022 Dec 5;:
pubmed: 36481453
Molecules. 2021 Jun 04;26(11):
pubmed: 34199888
Curr Hypertens Rep. 2021 Nov 11;23(10):42
pubmed: 34762198
Jpn J Ophthalmol. 2003 Mar-Apr;47(2):191-8
pubmed: 12738554
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3669-76
pubmed: 17652737
Can J Diet Pract Res. 2005 Summer;66(2):67-75
pubmed: 15975195
Nat Genet. 2018 Aug;50(8):1067-1071
pubmed: 30054594

Auteurs

Alyssa Grant (A)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Marie-Hélène Roy-Gagnon (MH)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Joseph Bastasic (J)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Akshay Talekar (A)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Mahsa Jessri (M)

School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.

Gisele Li (G)

Maisonneuve-Rosemont Hospital, Montreal, Canada.

Ralf Buhrmann (R)

Ottawa Eye Institute, The Ottawa Hospital, Ottawa, Canada.

Ellen E Freeman (EE)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.
Bruyère Research Institute, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH